We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALOG
701
DELISTED
Analogic Corp
ALOG
| $7.56M | 0.02% |
90,217
+8,600
| +11% | +$711K |
|
702
Puma Biotechnology
PBYI
$406M
| $7.54M | 0.02% |
76,300
+49,500
| +185% | +$5.54M |
|
|
LSXMK
703
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $7.53M | 0.02% |
249,197
+109,893
| +79% | +$3.49M |
|
|
MGP
704
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $7.47M | 0.02% |
256,139
-381,033
| -60% | -$11.2M |
|
705
Brixmor Property Group
BRX
$9.95B
| $7.46M | 0.02% |
399,996
+166,416
| +71% | +$3.04M |
|
706
Brighthouse Financial
BHF
$3.63B
| $7.46M | 0.02% |
+127,275
| New | +$7.53M |
|
707
Herc Holdings
HRI
$5.43B
| $7.45M | 0.02% |
+118,969
| New | +$6.55M |
|
|
EGOV
708
DELISTED
NIC Inc
EGOV
| $7.43M | 0.02% |
447,604
+84,900
| +23% | +$1.43M |
|
709
Enovis
ENOV
$1.56B
| $7.37M | 0.02% |
108,137
-44,073
| -29% | -$2.97M |
|
710
Quanta Services
PWR
$93.9B
| $7.36M | 0.02% |
188,083
-220,423
| -54% | -$8.27M |
|
711
Ionis Pharmaceuticals
IONS
$9.35B
| $7.34M | 0.02% |
145,911
+110,000
| +306% | +$6.03M |
|
712
QuidelOrtho
QDEL
$1.09B
| $7.33M | 0.02% |
169,201
-29,800
| -15% | -$1.22M |
|
|
BBBY
713
DELISTED
Bed Bath & Beyond Inc
BBBY
| $7.33M | 0.02% |
333,159
+289,900
| +670% | +$6.29M |
|
|
PCH
714
DELISTED
PotlatchDeltic
PCH
| $7.32M | 0.02% |
146,637
+52,400
| +56% | +$2.7M |
|
715
Oceaneering
OII
$5.25B
| $7.3M | 0.02% |
345,327
+57,200
| +20% | +$1.22M |
|
716
American Homes 4 Rent
AMH
$12B
| $7.28M | 0.02% |
333,438
+20,088
| +6% | +$436K |
|
717
Assured Guaranty
AGO
$3.78B
| $7.25M | 0.02% |
214,181
-23,600
| -10% | -$856K |
|
718
Coca-Cola
KO
$354B
| $7.22M | 0.02% |
157,290
+10,800
| +7% | +$496K |
|
|
TTM
719
DELISTED
Tata Motors Limited
TTM
| $7.19M | 0.02% |
217,500
+75,900
| +54% | +$2.45M |
|
720
First Hawaiian
FHB
$3.42B
| $7.19M | 0.02% |
246,300
-14,600
| -6% | -$427K |
|
721
Aramark
ARMK
$15B
| $7.17M | 0.02% |
+232,222
| New | +$7.1M |
|
722
Qualys
QLYS
$4.84B
| $7.09M | 0.02% |
119,500
+33,400
| +39% | +$1.88M |
|
|
CBM
723
DELISTED
Cambrex Corporation
CBM
| $7.08M | 0.02% |
147,463
+106,400
| +259% | +$5.27M |
|
724
UFP Industries
UFPI
$4.97B
| $7.05M | 0.02% |
187,318
+68,500
| +58% | +$2.52M |
|
725
Edgewell Personal Care
EPC
$1.27B
| $7.03M | 0.02% |
118,350
+51,100
| +76% | +$3.22M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.